Sihuan Pharmaceutical Holdings Group Ltd. (FRA:TEL1)

Germany flag Germany · Delayed Price · Currency is EUR
0.1590
+0.0130 (8.90%)
At close: Nov 28, 2025
97.52%
Market Cap1.36B
Revenue (ttm)249.33M
Net Income (ttm)-9.58M
Shares Outn/a
EPS (ttm)-0.00
PE Ration/a
Forward PEn/a
Dividend0.00 (0.75%)
Ex-Dividend DateSep 26, 2025
Volume6,000
Average Volume800
Open0.1470
Previous Close0.1460
Day's Range0.1470 - 0.1590
52-Week Range0.0605 - 0.2080
Betan/a
RSI53.58
Earnings DateNov 28, 2025

About FRA:TEL1

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China and the United States. It operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The company offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthet... [Read more]

Industry Pharmaceutical Preparations
Founded 2001
Employees 2,667
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol TEL1
Full Company Profile

Financial Performance

In 2024, FRA:TEL1's revenue was 1.90 billion, an increase of 2.18% compared to the previous year's 1.86 billion. Losses were -216.66 million, 301.1% more than in 2023.

Financial numbers in CNY Financial Statements

News

There is no news available yet.